Centers for Disease Control and Prevention | Interim considerations for COVID-19 vaccination of healthcare personnel and long-term care facility residents |
---|---|
COVID-19 vaccines vs variants — Determining how much immunity is enough | COVID-19 vaccines and allergic reactions |
Janssen COVID-19 vaccine: Fact sheet for recipients and caregivers.
22Vaccine Adverse Event Reporting System | FDA for emergency use authorization |
---|---|
Moderna announces primary efficacy analysis in phase 3 COVE study for its COVID-19 vaccine candidate and filing today with the U | Vaccine adverse event reporting system VAERS |
V-safe after vaccination health checker | Centers for Disease Control and Prevention |
---|---|
Centers for Disease Control and Prevention | Phased allocation of COVID-19 vaccines |
Interim public health recommendations for vaccinated people.
24